Conservation and innovation in the DUX4-family gene network

Nature Genetics

Volumn 49, Issue 6, 2017, Pages 935-940

  Whiddon, Jennifer L ^a,b   Langford, Ashlee T ^a   Wong, Chao Jen ^a   Zhong, Jun Wen ^a   Tapscott, Stephen J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DUX; TRANSCRIPTION FACTOR DUX4; UNCLASSIFIED DRUG; DUX4 PROTEIN, HUMAN; DUX4 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; RETROPOSON;

ALYREF GENE; ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DUXC GENE; EMBRYO; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRAME GENE; PRIORITY JOURNAL; PROMOTER REGION; RETROPOSON; RNA SEQUENCE; SKELETAL MUSCLE CELL; TRANSCRIPTION INITIATION SITE; USP17 GENE; ZSCAN4 GENE; ANIMAL; BINDING SITE; CELL CULTURE; CYTOLOGY; DOG; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; MYOBLAST; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; BINDING SITES; CELLS, CULTURED; DOGS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; HOMEODOMAIN PROTEINS; HUMANS; MICE, TRANSGENIC; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MYOBLASTS; RETROELEMENTS; TRANSCRIPTION INITIATION SITE;

EID: 85018247895     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3846     Document Type: Article

References (37)

1. Tawil, R., van der Maarel, S.M. & Tapscott, S.J. Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skelet. Muscle 4, 12 (2014).
2. Lek, A., Rahimov, F., Jones, P.L. & Kunkel, L.M. Emerging preclinical animal models for FSHD. Trends Mol. Med. 21, 295-306 (2015).
3. Wallace, L.M. et al. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann. Neurol. 69, 540-552 (2011).
4. Krom, Y.D. et al. Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD. PLoS Genet. 9, e1003415 (2013).
5. Dandapat, A. et al. Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene. Cell Rep. 8, 1484-1496 (2014).
6. Geng, L.N. et al. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev. Cell 22, 38-51 (2012).
7. Young, J.M. et al. DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis. PLoS Genet. 9, e1003947 (2013).
8. Bosnakovski, D., Daughters, R.S., Xu, Z., Slack, J.M. & Kyba, M. Biphasic myopathic phenotype of mouse DUX, an ORF within conserved FSHD-related repeats. PLoS One 4, e7003 (2009).
9. Leidenroth, A. et al. Evolution of DUX gene macrosatellites in placental mammals. Chromosoma 121, 489-497 (2012).
10. Leidenroth, A. & Hewitt, J.E. A family history of DUX4: phylogenetic analysis of DUXA, B, C and Duxbl reveals the ancestral DUX gene. BMC Evol. Biol. 10, 364 (2010).
11. Clapp, J. et al. Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 81, 264-279 (2007).
12. Eidahl, J.O. et al. Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4. Hum. Mol. Genet. 25, 4577-4589 (2016).
13. Knopp, P. et al. DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis. J. Cell Sci. 129, 3816-3831 (2016).
14. Falco, G. et al. Zscan4: a novel gene expressed exclusively in late 2-cell embryos and embryonic stem cells. Dev. Biol. 307, 539-550 (2007).
15. Zhang, W. et al. Zfp206 regulates ES cell gene expression and differentiation. Nucleic Acids Res. 34, 4780-4790 (2006).
16. Macfarlan, T.S. et al. Embryonic stem cell potency fluctuates with endogenous retrovirus activity. Nature 487, 57-63 (2012).
17. Akiyama, T. et al. Transient bursts of Zscan4 expression are accompanied by the rapid derepression of heterochromatin in mouse embryonic stem cells. DNA Res. 22, 307-318 (2015).
18. Jagannathan, S. et al. Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells. Hum. Mol. Genet. 25, 4419-4431 (2016).
19. NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 44, D7-D19 (2016).
20. Bailey, T.L. et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37, W202-W208 (2009).
21. Noyes, M.B. et al. Analysis of homeodomain specificities allows the family-wide prediction of preferred recognition sites. Cell 133, 1277-1289 (2008).
22. Peaston, A.E. et al. Retrotransposons regulate host genes in mouse oocytes and preimplantation embryos. Dev. Cell 7, 597-606 (2004).
23. Hendrickson, P.G. et al. Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL/HERVL retrotransposons. Nat. Genet. http://dx.doi.org/10.1038/ng.3844 (2017).
24. Bosnakovski, D. et al. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J. 27, 2766-2779 (2008).
25. Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
26. Trapnell, C., Pachter, L. & Salzberg, S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).
27. Love, M.I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
28. Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500-501 (2006).
29. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550 (2005).
30. Mi, H., Poudel, S., Muruganujan, A., Casagrande, J.T. & Thomas, P.D. PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res. 44 D1, D336-D342 (2016).
31. Conerly, M.L., Yao, Z., Zhong, J.W., Groudine, M. & Tapscott, S.J. Distinct activities of Myf5 and MyoD indicate separate roles in skeletal muscle lineage specification and differentiation. Dev. Cell 36, 375-385 (2016).
32. Cao, Y. et al. Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Dev. Cell 18, 662-674 (2010).
33. Liao, Y., Smyth, G.K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).
34. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
35. Ma, W., Noble, W.S. & Bailey, T.L. Motif-based analysis of large nucleotide data sets using MEME-ChIP. Nat. Protoc. 9, 1428-1450 (2014).
36. Bailey, T.L. & Elkan, C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 2, 28-36 (1994).
37. Edgar, R., Domrachev, M. & Lash, A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207-210 (2002).